Related Experiment Video
Updated: Jun 25, 2025

In vitro Organoid Culture of Primary Mouse Colon Tumors
Published on: May 17, 2013
Wogonin Inhibits Colorectal Cancer Proliferation and Epithelial Mesenchymal Transformation by Suppressing
Yujing Liu1,2, Lu Lu1,2, Peiqiu Cheng1
1Institute of Digestive Diseases, Longhua Hospital, China-Canada Center of Research for Digestive Diseases (ccCRDD), Shanghai University of Traditional Chinese Medicine, Shanghai 200032, P. R. China.
Abstract:
Colorectal cancer is the third leading cause of cancer-related death worldwide. Hence, there is a need to identify new therapeutic agents to improve the current repertoire of therapeutic drugs. Wogonin, a flavonoid from the herbal medicine Scutellaria baicalensis, has unique antitumor activity. Our study aimed to further explore the inhibitory effects of wogonin on colorectal cancer and its specific mechanism. The results showed that wogonin significantly inhibited the proliferation of colorectal cancer cells as well as their ability to invade and metastasize. We detected phosphorylation of tumor-associated signaling pathways using a phosphorylated protein microarray and found that wogonin intervention significantly inhibited the phosphorylation level of the AKT protein in colorectal cancer cells. Through in vitro and in vivo experiments, it was confirmed that wogonin exerted its antitumor effects against colorectal cancer by inhibiting phosphorylation in the AKT pathway. Our discovery of wogonin as an inhibitor of AKT phosphorylation provides new opportunities for the pharmacological treatment of colorectal cancer.
Insights
Wogonin, a compound from traditional Chinese medicine, effectively inhibits colorectal cancer growth and spread by targeting the AKT signaling pathway. This discovery offers a promising new therapeutic strategy for colorectal cancer treatment.
Area of Science:
- Oncology
- Pharmacology
- Natural Products
Background:
- Colorectal cancer (CRC) is a major global health concern and the third leading cause of cancer mortality.
- Existing therapies for CRC require improvement, necessitating the identification of novel therapeutic agents.
- Wogonin, a flavonoid derived from *Scutellaria baicalensis*, exhibits potential antitumor properties.
Purpose of the Study:
- To investigate the inhibitory effects of wogonin on colorectal cancer proliferation, invasion, and metastasis.
- To elucidate the underlying molecular mechanism of wogonin's antitumor activity in colorectal cancer.
Main Methods:
- Utilized a phosphorylated protein microarray to analyze signaling pathway phosphorylation in colorectal cancer cells.
- Conducted *in vitro* and *in vivo* experiments to validate wogonin's efficacy and mechanism of action.
- Assessed the impact of wogonin on colorectal cancer cell proliferation, invasion, and metastasis.
Main Results:
- Wogonin significantly suppressed colorectal cancer cell proliferation, invasion, and metastasis.
- Wogonin intervention markedly reduced the phosphorylation of the AKT protein in colorectal cancer cells.
- Confirmed that wogonin exerts its antitumor effects by inhibiting AKT pathway phosphorylation.
Conclusions:
- Wogonin demonstrates significant antitumor activity against colorectal cancer.
- The mechanism involves the inhibition of AKT protein phosphorylation.
- Wogonin represents a potential new pharmacological treatment for colorectal cancer by targeting the AKT pathway.
More Related Videos
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Canonical Wnt Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Inhibition of Cdk Activity
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...